1964
DOI: 10.1001/archinte.1964.00280110059012
|View full text |Cite
|
Sign up to set email alerts
|

Disseminated Herpes Zoster

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
37
1
5

Year Published

1967
1967
2012
2012

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 141 publications
(43 citation statements)
references
References 11 publications
0
37
1
5
Order By: Relevance
“…During an illness that suppresses the immune system, the virus is reactivated and travels to the end of the nerve cell, where it causes the symptoms described above [1]. This complication of zoster has been described in immunocompromised persons (HIV, cancer, patients on immunosuppressive therapy) and reported to be as common as 10%-40% [3,4]. However, Herpes zoster oticus in otherwise healthy persons who are not on immunosuppressive therapy and have no underlying cancer is rare.…”
Section: Discussionmentioning
confidence: 99%
“…During an illness that suppresses the immune system, the virus is reactivated and travels to the end of the nerve cell, where it causes the symptoms described above [1]. This complication of zoster has been described in immunocompromised persons (HIV, cancer, patients on immunosuppressive therapy) and reported to be as common as 10%-40% [3,4]. However, Herpes zoster oticus in otherwise healthy persons who are not on immunosuppressive therapy and have no underlying cancer is rare.…”
Section: Discussionmentioning
confidence: 99%
“…Although this concern is largely theoretical, Merselis and colleagues 4 described a series of case reports in 1964 in which 17 of 175 patients developed disseminated herpes zoster. Five of the 17 patients were receiving corticosteroids or adrenocorticotropin hormone (ACfH).…”
Section: Safetymentioning
confidence: 99%
“…These condi tions are sometimes induced by impaired host resistances , for example, delay of antibody response (Miller and Brunch 1970) or decline of local host defenses by x-ray irradiation (Guss et al 1971). Merselis et al (1964) reported that 11 of 17 patients with disseminated herpes zoster had serious underlying diseases. Nine of 11 patients with underlying diseases were receiving adrenocorticosteroids , x-ray therapy or radiomimetic drugs.…”
Section: Two Patientsmentioning
confidence: 99%